Updated Jul 16, 2026 · Last SEC filing 2026-06-24
OnKure Therapeutics, Inc. (OKUR) has filed 8 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-24. 2 Form 8-K material event filings were reported by OKUR in the last 90 days. InsiderAlpha tracks every OKUR SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SIC classification | Pharmaceutical Preparations (SIC 2834) |
|---|---|
| SEC CIK | 0001637715 |
| Form 4 filings (90d) | 8 |
|---|---|
| Form 8-K filings (90d) | 2 |
| Latest Form 4 filing | 2026-06-24 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Leverone Jason A. | Chief Financial Officer | S — Open-market sale | 303 | $4.40 | $1K | SEC | |
| Saccomano Nicholas A | President and CEO | S — Open-market sale | 86 | $4.40 | $378 | SEC | |
| Saccomano Nicholas A | President and CEO | S — Open-market sale | 86 | $4.16 | $357 | SEC | |
| Leverone Jason A. | Chief Financial Officer | S — Open-market sale | 301 | $4.16 | $1K | SEC | |
| Mathers Edward T | Insider | A — Grant or award | 3.9K | $0.00 | — | SEC | |
| Mathers Edward T | Insider | A — Grant or award | 4.1K | $0.00 | — | SEC | |
| Manke Isaac | Insider | A — Grant or award | 5.5K | $0.00 | — | SEC | |
| Leverone Jason A. | Chief Financial Officer | S — Open-market sale | 303 | $2.62 | $795 | SEC | |
| Saccomano Nicholas A | President and CEO | S — Open-market sale | 88 | $2.62 | $231 | SEC | |
| Mathers Edward T | Insider | A — Grant or award | 4.7K | $0.00 | — | SEC | |
| Manke Isaac | Insider | A — Grant or award | 6.3K | $0.00 | — | SEC | |
| Leonard Braden Michael | Insider | J — Other acquisition / disposition | 345.7K | — | — | SEC | |
| Leonard Braden Michael | Insider | J — Other acquisition / disposition | 102.1K | — | — | SEC | |
| Carruthers R Michael | Insider | A — Grant or award | 4.1K | — | — | SEC | |
| Carruthers R Michael | Insider | A — Grant or award | 874 | — | — | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for OnKure Therapeutics, Inc. (OKUR). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Mathers Edward T | 1 | — |
| GREY MICHAEL G | 1 | — |
| Saccomano Nicholas A | 1 | $378 |
| Leverone Jason A. | 1 | $1K |
| Carruthers R Michael | 1 | — |
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in OKUR insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live OKUR dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.